Provided by Tiger Trade Technology Pte. Ltd.

Puma Biotechnology

10.29
+0.32003.21%
Post-market: 10.500.2100+2.04%19:58 EDT
Volume:303.06K
Turnover:3.10M
Market Cap:531.17M
PE:20.43
High:10.36
Open:9.96
Low:9.85
Close:9.97
52wk High:10.36
52wk Low:4.58
Shares:51.62M
Float Shares:41.97M
Volume Ratio:0.84
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5036
EPS(LYR):0.6100
ROE:21.97%
ROA:9.81%
PB:3.83
PE(LYR):16.87

Loading ...

Puma Biotechnology Grants 7,500 Inducement Restricted Stock Units to New Employee

Reuters
·
Oct 06

Puma Biotechnology Reports Inducement Award Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Oct 06

Puma Biotechnology Launches Phase II Alisca-Lung2 Trial of Alisertib Plus Paclitaxel in Advanced Small Cell Lung Cancer

Reuters
·
Sep 18

Puma Biotechnology Initiates Alisca®-Lung2, a Phase Ii Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with Advanced Small Cell Lung Cancer

THOMSON REUTERS
·
Sep 18

Puma Biotechnology Director Alessandra Cesano Disposes of 62,150 Common Shares Worth $566,437.45

Reuters
·
Sep 17

Puma Biotechnology CEO Alan Auerbach Presents at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 10

Puma Biotechnology Grants Inducement RSUs Covering 33,550 Shares to Five New Hires

Reuters
·
Sep 04

Puma Biotechnology Reports Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 04

Analysts Offer Insights on Healthcare Companies: Neuren Pharmaceuticals Limited (OtherNURPF) and Puma Biotechnology (PBYI)

TIPRANKS
·
Aug 07

Puma Biotech Posts Q2 2026 Financial Results Presentation Webcast Report

Reuters
·
Aug 07

Puma Biotechnology Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Puma Biotechnology Q2 FY26 GAAP Net Income Rises 38.98% to $8.2 Million; Revenue Increases 7.82% to $56.5 Million

Reuters
·
Aug 07

Puma Biotechnology Q2 Adj. EPS $0.19 Beats $0.04 Estimate, Sales $53.600M Beat $53.000M Estimate

Benzinga Earnings
·
Aug 07

Puma Biotechnology Q2 Adjusted EPS USD 0.2

Reuters
·
Aug 07

Puma Biotechnology - Raises Fy2026 Total Revenue Guidance to $224-231 Mln

THOMSON REUTERS
·
Aug 07

Corrected-Puma Biotechnology Q2 Adjusted EPS USD 0.19 (Corrects Amount)

THOMSON REUTERS
·
Aug 07

Puma Biotechnology Grants 35,375 Inducement RSUs to Five New Employees

Reuters
·
Aug 06

Puma Biotechnology Reports Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 06

Puma Biotechnology Inc Expected to Post Earnings of 4 Cents a Share - Earnings Preview

Reuters
·
Aug 05

Press Release: Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results

Dow Jones
·
Jul 24